These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35621089)
21. Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model. Waksman R; Zumstein P; Pritsch M; Wittchow E; Haude M; Lapointe-Corriveau C; Leclerc G; Joner M EuroIntervention; 2017 Jul; 13(4):440-449. PubMed ID: 28262623 [TBL] [Abstract][Full Text] [Related]
22. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Serruys PW; Chevalier B; Sotomi Y; Cequier A; Carrié D; Piek JJ; Van Boven AJ; Dominici M; Dudek D; McClean D; Helqvist S; Haude M; Reith S; de Sousa Almeida M; Campo G; Iñiguez A; Sabaté M; Windecker S; Onuma Y Lancet; 2016 Nov; 388(10059):2479-2491. PubMed ID: 27806897 [TBL] [Abstract][Full Text] [Related]
24. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry. La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959 [TBL] [Abstract][Full Text] [Related]
25. The Current Literature on Bioabsorbable Stents: a Review. Omar WA; Kumbhani DJ Curr Atheroscler Rep; 2019 Nov; 21(12):54. PubMed ID: 31768641 [TBL] [Abstract][Full Text] [Related]
26. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation. Seguchi M; Aytekin A; Lenz T; Nicol P; Alvarez-Covarrubias HA; Xhepa E; Klosterman GR; Beele A; Sabic E; Utsch L; Alyaqoob A; Joner M J Cardiol; 2023 Feb; 81(2):179-188. PubMed ID: 36122642 [TBL] [Abstract][Full Text] [Related]
27. Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry. Galli S; Troiano S; Palloshi A; Rapetto C; Pisano F; Aprigliano G; Leoncini M; Ravagnani P; Del Maestro M; Montorsi P Cardiovasc Revasc Med; 2022 Aug; 41():69-75. PubMed ID: 35256294 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold. Madanchi M; Cioffi GM; Attinger-Toller A; Wolfrum M; Moccetti F; Seiler T; Vercelli L; Burkart P; Toggweiler S; Kobza R; Bossard M; Cuculi F Open Heart; 2021 Sep; 8(2):. PubMed ID: 34518287 [TBL] [Abstract][Full Text] [Related]
29. Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model. Waksman R; Lipinski MJ; Acampado E; Cheng Q; Adams L; Torii S; Gai J; Torguson R; Hellinga DM; Westman PC; Joner M; Zumstein P; Kolodgie FD; Virmani R Circ Cardiovasc Interv; 2017 Aug; 10(8):. PubMed ID: 28801538 [TBL] [Abstract][Full Text] [Related]
30. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study. Hommels TM; Hermanides RS; Rasoul S; Berta B; IJsselmuiden AJJ; Jessurun GAJ; Benit E; Pereira B; De Luca G; Kedhi E Cardiovasc Diabetol; 2019 Mar; 18(1):25. PubMed ID: 30851731 [TBL] [Abstract][Full Text] [Related]
31. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials? Rizik DG; Hermiller JB; Simonton CA; Klassen KJ; Kereiakes DJ Coron Artery Dis; 2017 Jan; 28(1):77-89. PubMed ID: 27561169 [TBL] [Abstract][Full Text] [Related]